Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Facilitatory effects of anti-spastic medication on robotic locomotor training in people with chronic incomplete spinal cord injury

Facilitatory effects of anti-spastic medication on robotic locomotor training in people with chronic incomplete spinal cord injury

Journal of NeuroEngineering and Rehabilitation, 2015 · DOI: 10.1186/s12984-015-0018-4 · Published: February 19, 2015

Spinal Cord InjuryRehabilitationBiomedical

Simple Explanation

This study investigates if Tizanidine, an anti-spasticity medication, can help people with incomplete spinal cord injuries improve their walking ability when combined with robotic locomotor treadmill training (LTT). The study found that while both LTT alone and LTT with Tizanidine improved walking speed, a higher percentage of people using both treatments showed clinically meaningful improvements. The researchers suggest that Tizanidine might help by improving ankle movement, potentially due to reduced muscle stiffness, especially in those who were already relatively higher functioning.

Study Duration
4 weeks
Participants
LTT alone (n = 26) or LTT combined with Tizanidine (n = 22)
Evidence Level
Not specified

Key Findings

  • 1
    Both LTT and TizLTT resulted in significant improvements in walking speed and dorsiflexion maximum strength, with no significant differences between them, using group-averaging analysis.
  • 2
    A higher proportion of subjects in the TizLTT group achieved the MID for walking speed (40%) compared with LTT alone (13%).
  • 3
    The change in walking speed was associated with the change in dorsiflexion peak velocity (R2 = 0.40; P < 0.05).

Research Summary

The study investigated whether the anti-spasticity medication Tizanidine could enhance the effects of robotic locomotor treadmill training (LTT) on gait function in individuals with chronic incomplete spinal cord injury (SCI). Both LTT and TizLTT improved walking speed and dorsiflexion strength. However, a larger proportion of subjects in the TizLTT group achieved the minimal important difference (MID) for walking speed. The findings suggest that Tizanidine may facilitate the effects of LTT on gait function, particularly in higher-functioning individuals, potentially by improving ankle dorsiflexion through reduced spasticity in plantarflexors.

Practical Implications

Combined Therapy

Combining Tizanidine with LTT may be more effective than LTT alone for improving gait function in individuals with chronic incomplete SCI.

Targeted Treatment

Tizanidine may be particularly beneficial for higher-functioning individuals with SCI undergoing locomotor training.

Mechanism of Action

The facilitatory effect of Tizanidine may be related to improved ankle dorsiflexion due to reduced spasticity in plantarflexors.

Study Limitations

  • 1
    Relatively low dose of Tizanidine was used.
  • 2
    Short intervention period (4 weeks or 12 LTT sessions).
  • 3
    No control group (no intervention) in this study.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury